IP Library Granted Patent US 9,833,488
Granted Patent B2
US 9,833,488 · App. 14/395,919 · Granted Dec 5, 2017

Sensitization composition and method of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,833,488
App. No.
14/395,919
Granted
Dec 5, 2017
Kind
B2
Abstract

The present invention relates to a topical composition and method of use, specifically an oil-in-water emulsion, comprised of sweet almond oil, lavender oil, rose oil, cinnamon bark oil, and coriander seed oil in a physiologically acceptable topical carrier. The composition is applied to a circumcised penis to enhance sensitivity, preferably twice daily for a time period of at least about two weeks. Thereafter a maintenance dose can be applied once a day to maintain a desired level of sensitivity.

Claims (7)

1. A topical sensitization composition comprising an effective amount of an admixture of sweet almond oil, lavender oil, cinnamon bark oil, coriander seed oil and rose oil, wherein the oils are present in said admixture at a respective weight ratio of about 200:33:25:17:1; and

wherein the composition is in the form of a physiologically acceptable oil-in-water emulsion.

2. The topical composition in accordance with claim 1 wherein the oil-in-water emulsion has the consistency of a topical cream.

3. A topical oil-in-water emulsion sensitization cream composition comprising, based on the weight of the composition:

about 2 to about 10 weight percent sweet almond oil, about 0.01 to about 2 weight percent lavender oil, about 0.005 to about 1 weight percent of rose oil, about 0.01 to about 2 weight percent cinnamon bark oil, about 0.01 to about 1 weight percent of coriander seed oil, about 0.7 to about 7 weight percent sorbitol, zero to about 7 weight percent isopropyl alcohol, about 5 to about 25 weight percent of propylene glycol, about 0.01 to about 2 weight percent butylated hydroxytoluene, about 0.05 to about 3 weight percent triethanolamine, about 0.01 to about 3 weight percent benzyl alcohol, about 0.01 to about 5 weight percent benzyl benzoate, about 1 to about 5 weight percent of polyethylene glycol (40)-hydrogenated castor oil, about 0.25 to about 4 weight percent acrylate/C10-30 alkyl acrylate crosspolymer, about 0.01 to about 0.2 weight percent disodium ethylene diamine tetraacetic acid, and the remainder water.

4. The topical composition of claim 3 and consisting essentially of, based on the weight of the composition:

about 6 weight percent sweet almond oil, about 1 weight percent lavender oil, about 0.03 weight percent of rose oil, about 0.75 weight percent cinnamon bark oil, about 0.5 weight percent coriander seed oil, about 3.5 weight percent sorbitol, about 2.8 weight percent isopropyl alcohol, about 20 weight percent propylene glycol, about 1 weight percent butylated hydroxytoluene, about 1 weight percent triethanolamine, about 1 weight percent benzyl alcohol, about 1 weight percent benzyl benzoate, about 3.5 weight percent polyethylene glycol (40)-hydrogenated castor oil, about 1.3 weight percent acrylate/C10-30 alkyl acrylate crosspolymer, about 0.1 weight percent disodium ethylene diamine tetraacetic acid, and the remainder water.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jun 14, 2024
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: INNOVUS PHARMACEUTICALS, INC.
Reel/Frame 067728/0206 →
PARTIAL RELEASE OF SECURITY INTEREST IN PATENTS Recorded Oct 16, 2023
From: ECLIPSE BUSINESS CAPITAL LLC (F/K/A ENCINA BUSINESS CREDIT, LLC), AS AGENT
To: INNOVUS PHARMACEUTICALS, INC.; SEMPRAE LABORATORIES, INC.; AYTU BIOPHARMA, INC.; NOVALERE, INC.
Reel/Frame 065241/0560 →
SECURITY INTEREST Recorded Feb 10, 2022
From: INNOVUS PHARMACEUTICALS, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 058976/0706 →
SECURITY INTEREST Recorded Jan 27, 2022
From: INNOVUS PHARMACEUTICALS, INC.; SEMPRAE LABORATORIES, INC.
To: ECLIPSE BUSINESS CAPITAL LLC (F/K/A ENCINA BUSINESS CREDIT, LLC), AS AGENT
Reel/Frame 058789/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2020
From: CENTRIC RESEARCH INSTITUTE, INC.
To: INNOVUS PHARMACEUTICALS, INC.
Reel/Frame 051714/0824 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2020
From: CENTRIC RESEARCH INSTITUTE, INC.
To: INNOVUS PHARMACEUTICALS, INC.
Reel/Frame 051649/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2015
From: BUYUKTIMKIN, SERVET; BUYUKTIMKIN, NADIR; YEAGER, JAMES L.; LIU, ALBERT
To: CENTRIC RESEARCH INSTITUTE
Reel/Frame 034909/0712 →